Pai M, Key N S, Skinner M, Curtis R, Feinstein M, Kessler C, Lane S J, Makris M, Riker E, Santesso N, Soucie J M, Yeung C H T, Iorio A, Schünemann H J
Department of Medicine, McMaster University, Hamilton, ON, Canada.
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Haemophilia. 2016 Jul;22 Suppl 3:6-16. doi: 10.1111/hae.13008.
This guideline was developed to identify evidence-based best practices in haemophilia care delivery, and discuss the range of care providers and services that are most important to optimize outcomes for persons with haemophilia (PWH) across the United States. The guideline was developed following specific methods described in detail in this supplement and based on the GRADE (Grading of Recommendations, Assessment, Development and Evaluation approach). Direct evidence from published literature and the haemophilia community, as well as indirect evidence from other chronic diseases, were reviewed, synthesized and applied to create evidence-based recommendations. The Guideline panel suggests that the integrated care model be used over non-integrated care models for PWH (conditional recommendation, moderate certainty in the evidence). For PWH with inhibitors and those at high risk for inhibitor development, the same recommendation was graded as strong, with moderate certainty in the evidence. The panel suggests that a haematologist, a specialized haemophilia nurse, a physical therapist, a social worker and round-the-clock access to a specialized coagulation laboratory be part of the integrated care team, over an integrated care team that does not include all of these components (conditional recommendation, very low certainty in the evidence). Based on available evidence, the integrated model of care in its current structure, is suggested for optimal care of PWH. There is a need for further appropriately designed studies that address unanswered questions about specific outcomes and the optimal structure of the integrated care delivery model in haemophilia.
本指南旨在确定血友病护理中的循证最佳实践,并讨论对优化美国血友病患者(PWH)治疗效果最为重要的各类护理提供者和服务。本指南是按照本增刊详细描述的特定方法,并基于GRADE(推荐分级、评估、制定与评价方法)制定的。对已发表文献和血友病群体的直接证据,以及其他慢性病的间接证据进行了审查、综合和应用,以制定循证建议。指南小组建议,对于PWH采用综合护理模式而非非综合护理模式(有条件推荐,证据的确定性为中等)。对于有抑制物的PWH以及有发展为抑制物高风险的患者,同样的建议被评为强烈推荐,证据的确定性为中等。该小组建议,综合护理团队应包括血液科医生、专业血友病护士、物理治疗师、社会工作者以及全天候可使用的专业凝血实验室,而不是不包括所有这些组成部分的综合护理团队(有条件推荐,证据的确定性非常低)。基于现有证据,建议采用当前结构的综合护理模式来实现对PWH的最佳护理。有必要开展进一步设计合理的研究,以解决有关血友病特定治疗效果以及综合护理模式最佳结构的未决问题。